Fecal Transplant War Pits Doctors And Pharma Against Each Other In Dirty Battle Over Future Of Treatment

At the crux of the matter: should fecal transplants be treated like a drug or like other organ transplants? The answer will determine how the FDA regulates the procedure, how much it costs and who gets to profit. In other pharmaceutical news: out-of-pocket costs for prescription drugs, patient advocacy groups' ties to pharma; and kickbacks from drugmakers.

from Kaiser Health News https://ift.tt/2Hf38pa